Lei Chen
Director/Board Member at SHANGHAI XFH TECHNOLOGY CO., LTD
Lei Chen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SHANGHAI XFH TECHNOLOGY CO., LTD | Director/Board Member | 19/01/2016 | - |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Director/Board Member | - | - |
Career history of Lei Chen
Training of Lei Chen
| Tsinghua University | Graduate Degree |
Statistics
International
| China | 4 |
Operational
| Director/Board Member | 2 |
| Graduate Degree | 1 |
Sectoral
| Producer Manufacturing | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SHANGHAI XFH TECHNOLOGY CO., LTD | Producer Manufacturing |
| Private companies | 1 |
|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Stock Market
- Insiders
- Lei Chen
- Experience
